Polymeric Biosufactants
AssigneeTherapeutic Peptides, Inc.
InventorsDonald Owen, Lili Fan
Life of this patent
Estimating the term…
Loading patent…
AssigneeTherapeutic Peptides, Inc.
InventorsDonald Owen, Lili Fan
Estimating the term…
The present invention is directed to biosurfactants that can self-assemble or auto-aggregate into polymeric micellar structures and their use in topically-applied dermatologic products. The invention relates in particular to polymeric acylated biosurfactants (PABs) conforming to the formula Acyl-AA-Term where Acyl is an 8- to 22-membered carbon chain, branched or unbranched, saturated or unsaturated, AA is a consecutive sequence of four to nine amino acid residues, where at least one, preferably at least two of the amino acid residues is charged, and Term is an acid C-terminus or an amide C-terminus. PABs of the present invention have low critical micelle concentrations (predominantly less than about 100 ppm) in an aqueous environment of Minimal Essential Media (MEM) and can lower the surface tension in the aqueous MEM environment to less about 50 dynes/cm2. They also have the ability to increase metabolic soluble proteins.
A process for lowering the surface tension in an aqueous MEM environment to less than about 50 dynes/cm2 comprising administering a polymeric acylated biosurfactant conforming to the formula Acyl-AA-Term where
23-38. (canceled)
A topically-applied cosmetic or dermatologic composition comprising (i) a polymeric acylated biosurfactant at a concentration of at least about 1 ppm selected from the group consisting of SEQ ID NO:
Dependencies are inferred from the claim text.